Scarica l'app Stockscreener
97.71
1.03%
-1.02
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$98.73
Aprire:
$98.42
Volume 24 ore:
210.86K
Relative Volume:
0.47
Capitalizzazione di mercato:
$2.12B
Reddito:
$486.82M
Utile/perdita netta:
$18.78M
Rapporto P/E:
119.16
EPS:
0.82
Flusso di cassa netto:
$100.45M
1 W Prestazione:
+2.48%
1M Prestazione:
+10.61%
6M Prestazione:
+54.46%
1 anno Prestazione:
+74.02%
Intervallo 1D:
$97.18
$99.10
Intervallo di 1 settimana:
$94.31
$99.50
Portata 52W:
$52.50
$99.50
Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
Nome
Ani Pharmaceuticals Inc
Settore
Telefono
(218) 634-3500
Indirizzo
210 MAIN STREET WEST, BAUDETTE, MN
Confronta ANIP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANIP
Ani Pharmaceuticals Inc
|
97.71 | 2.11B | 486.82M | 18.78M | 100.45M | 0.82 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-10 | Iniziato | H.C. Wainwright | Buy |
| 2025-03-14 | Iniziato | Jefferies | Buy |
| 2025-03-12 | Iniziato | JP Morgan | Overweight |
| 2024-12-11 | Iniziato | Leerink Partners | Outperform |
| 2024-10-11 | Iniziato | Piper Sandler | Overweight |
| 2024-03-15 | Iniziato | CapitalOne | Overweight |
| 2023-08-22 | Reiterato | H.C. Wainwright | Buy |
| 2023-03-01 | Iniziato | Guggenheim | Buy |
| 2022-09-07 | Iniziato | H.C. Wainwright | Buy |
| 2021-11-02 | Iniziato | Truist | Buy |
| 2020-05-07 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2019-09-12 | Iniziato | Guggenheim | Buy |
| 2019-05-10 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2017-10-16 | Reiterato | Canaccord Genuity | Buy |
| 2017-07-31 | Iniziato | Canaccord Genuity | Buy |
| 2017-02-22 | Downgrade | ROTH Capital | Buy → Neutral |
| 2016-06-23 | Iniziato | Raymond James | Strong Buy |
| 2016-05-24 | Downgrade | Standpoint Research | Buy → Hold |
| 2015-11-13 | Iniziato | Standpoint Research | Buy |
| 2015-09-28 | Aggiornamento | ROTH Capital | Neutral → Buy |
| 2015-08-05 | Reiterato | Oppenheimer | Outperform |
| 2015-08-04 | Reiterato | ROTH Capital | Neutral |
| 2015-07-31 | Reiterato | Oppenheimer | Outperform |
| 2015-07-15 | Reiterato | ROTH Capital | Neutral |
| 2015-06-23 | Reiterato | Oppenheimer | Outperform |
| 2015-05-18 | Reiterato | ROTH Capital | Neutral |
| 2015-05-06 | Reiterato | Oppenheimer | Outperform |
| 2015-04-10 | Downgrade | ROTH Capital | Buy → Neutral |
| 2015-02-26 | Reiterato | ROTH Capital | Buy |
| 2015-02-18 | Reiterato | Oppenheimer | Outperform |
Mostra tutto
Ani Pharmaceuticals Inc Borsa (ANIP) Ultime notizie
Comerica Bank Sells 7,280 Shares of ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals, Inc. $ANIP Shares Purchased by Federation des caisses Desjardins du Quebec - MarketBeat
Millennium Management LLC Lowers Stock Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals, Inc. $ANIP Shares Sold by Great Lakes Advisors LLC - MarketBeat
Parkman Healthcare Partners LLC Purchases New Stake in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals (NASDAQ:ANIP) Sets New 1-Year High on Analyst Upgrade - MarketBeat
ANI Pharmaceuticals (NASDAQ:ANIP) Price Target Raised to $114.00 at Guggenheim - MarketBeat
ANI Pharmaceuticals, Inc. $ANIP Shares Acquired by Northern Trust Corp - MarketBeat
Transcript : ANI Pharmaceuticals, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-09-2025 01 - MarketScreener
Is ANI Pharmaceuticals Inc. stock a hidden gemQuarterly Earnings Report & High Conviction Trade Alerts - Lancaster City Council
Ani Pharmaceuticals stock hits 52-week high at 96.61 USD - Investing.com
Is ANI Pharmaceuticals Inc. forming higher highs and higher lowsQuarterly Growth Report & Fast Exit and Entry Strategy Plans - Lancaster City Council
Ani Pharmaceuticals stock hits 52-week high at 96.61 USD By Investing.com - Investing.com Nigeria
ANI Pharmaceuticals, Inc. (ANIP) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
ANI Pharmaceuticals at H.C. Wainwright: Driving Growth in Rare Diseases By Investing.com - Investing.com Canada
Earnings Chart Overlay Points to ANI Pharmaceuticals Inc. UpsideJuly 2025 Levels & Free High Return Stock Watch Alerts - beatles.ru
AYAL Capital Advisors Ltd Buys New Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals (NASDAQ:ANIP) Reaches New 1-Year HighWhat's Next? - MarketBeat
Can machine learning forecast ANI Pharmaceuticals Inc. recovery2025 Sector Review & Stock Portfolio Risk Control - Newser
Is ANI Pharmaceuticals Inc. a cyclical or defensive stockJuly 2025 Retail & Weekly Hot Stock Watchlists - خودرو بانک
Is ANI Pharmaceuticals Inc. forming a bottoming baseWeekly Volume Report & Real-Time Volume Analysis Alerts - Newser
8,206 Shares in ANI Pharmaceuticals, Inc. $ANIP Bought by Wellington Management Group LLP - MarketBeat
Published on: 2025-09-05 23:12:27 - خودرو بانک
Is ANI Pharmaceuticals Inc. a strong growth stock2025 Market Sentiment & Smart Investment Allocation Insights - خودرو بانک
What to do if you’re stuck in ANI Pharmaceuticals Inc.July 2025 Gainers & Precise Buy Zone Identification - Newser
Should I set a stop loss on ANI Pharmaceuticals Inc.2025 AllTime Highs & Long-Term Capital Growth Ideas - خودرو بانک
What data driven models say about ANI Pharmaceuticals Inc.’s future - Newser
Is ANI Pharmaceuticals Inc.’s growth already priced in2025 Earnings Impact & Advanced Swing Trade Entry Plans - خودرو بانک
Apis Capital Advisors LLC Makes New $4.35 Million Investment in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
What is ANI Pharmaceuticals Inc.’s book value per share2025 Market WrapUp & Safe Entry Trade Reports - خودرو بانک
ANI Pharmaceuticals Inc. stock outlook for YEAR2025 Technical Overview & Free Risk Controlled Daily Trade Plans - Newser
Forecasting ANI Pharmaceuticals Inc. price range with options dataWeekly Gains Summary & Growth Oriented Trading Recommendations - Newser
What Fibonacci levels say about ANI Pharmaceuticals Inc. reboundQuarterly Portfolio Report & Free Community Supported Trade Ideas - Newser
Technical signs of recovery in ANI Pharmaceuticals Inc.July 2025 Movers & Daily Oversold Bounce Ideas - Newser
How to monitor ANI Pharmaceuticals Inc. with trend dashboardsMarket Volume Report & Risk Adjusted Swing Trade Ideas - Newser
Leading vs lagging indicators on ANI Pharmaceuticals Inc. performanceMarket Performance Recap & Reliable Price Breakout Alerts - Newser
What technical models suggest about ANI Pharmaceuticals Inc.’s comebackJobs Report & Community Consensus Trade Signals - Newser
Fed Meeting: Is ANI Pharmaceuticals Inc. stock forming a cup and handleCEO Change & Safe Entry Trade Signal Reports - خودرو بانک
Should you hold or exit ANI Pharmaceuticals Inc. nowWall Street Watch & Verified Momentum Stock Watchlist - Newser
Aug Swings: Is ANI Pharmaceuticals Inc.’s growth already priced inLayoff News & Weekly Market Pulse Alerts - خودرو بانک
What machine learning models say about ANI Pharmaceuticals Inc.Portfolio Return Report & Free Reliable Trade Execution Plans - Newser
Using R and stats models for ANI Pharmaceuticals Inc. forecasting2025 Support & Resistance & Safe Entry Zone Tips - Newser
Can trapped investors hope for a rebound in ANI Pharmaceuticals Inc.Market Sentiment Review & Growth Focused Stock Pick Reports - Newser
Walleye Capital LLC Has $2.09 Million Stock Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Ani Pharmaceuticals shares rise 1.98% after-hours following CG Oncology's PIVOT-006 study enrollment completion. - AInvest
Is this a good reentry point in ANI Pharmaceuticals Inc.Portfolio Risk Report & Weekly High Potential Stock Alerts - Newser
Sector ETF performance correlation with ANI Pharmaceuticals Inc.Weekly Loss Report & Free Real-Time Market Sentiment Alerts - Newser
Nuveen LLC Takes Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Best data tools to analyze ANI Pharmaceuticals Inc. stock2025 Trade Ideas & AI Based Buy/Sell Signal Reports - Newser
Is ANI Pharmaceuticals Inc. stock good for income investorsTrade Analysis Summary & Daily Profit Maximizing Trade Tips - خودرو بانک
Published on: 2025-09-02 23:11:03 - Newser
Ani Pharmaceuticals Inc Azioni (ANIP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.67%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):